Mitomycin and Mitoxantrone in Treating Patients With Acute Myelogenous Leukemia

NCT00003003 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

29

Enrollment

OTHER

Sponsor class

Conditions

Leukemia

Interventions

BIOLOGICAL: sargramostim
DRUG: mitomycin C
DRUG: mitoxantrone hydrochloride

Sponsor

Dartmouth-Hitchcock Medical Center

Collaborators

[object Object]